Literature DB >> 9519397

Gene therapy in sports medicine.

C Lamsam1, F H Fu, P D Robbins, C H Evans.   

Abstract

Sports injuries frequently involve tissues that have limited healing capabilities. In order to improve the healing process and thus prevent the serious consequences of injury, it is necessary to understand the molecular and cellular biology of healing. Several growth factors and other cytokines have been identified as important mediators of a successful healing process. Such molecules have promise as novel agents for the treatment of sporting injuries, but there is presently no clinically useful way to deliver them. Gene transfer may be used to serve this purpose. In this role, gene therapy functions as a type of local biological drug delivery system. Recent studies have shown the feasibility of transferring marker genes to synovium, chondrocytes, meniscal fibrochondrocytes, tenocytes and ligamental fibroblasts, prompting optimism about the eventual success of this approach.

Mesh:

Year:  1998        PMID: 9519397     DOI: 10.2165/00007256-199825020-00001

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  25 in total

1.  Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study.

Authors:  R Kang; T Marui; S C Ghivizzani; I M Nita; H I Georgescu; J K Suh; P D Robbins; C H Evans
Journal:  Osteoarthritis Cartilage       Date:  1997-03       Impact factor: 6.576

2.  Safety and effect of transforming growth factor-beta(2) for treatment of venous stasis ulcers.

Authors:  M C Robson; L G Phillip; D M Cooper; W G Lyle; L E Robson; L Odom; D P Hill; A F Hanham; G A Ksander
Journal:  Wound Repair Regen       Date:  1995 Apr-Jun       Impact factor: 3.617

3.  Effect of growth factors on the proliferation of fibroblasts from the medial collateral and anterior cruciate ligaments.

Authors:  C C Schmidt; H I Georgescu; C K Kwoh; G L Blomstrom; C P Engle; L A Larkin; C H Evans; S L Woo
Journal:  J Orthop Res       Date:  1995-03       Impact factor: 3.494

4.  Patellar tendon and anterior cruciate ligament have different mitogenic responses to platelet-derived growth factor and transforming growth factor beta.

Authors:  K P Spindler; A K Imro; C E Mayes; J M Davidson
Journal:  J Orthop Res       Date:  1996-07       Impact factor: 3.494

5.  Adenovirus-mediated gene transfer into tendon and tendon sheath.

Authors:  J Lou; P R Manske; M Aoki; M E Joyce
Journal:  J Orthop Res       Date:  1996-07       Impact factor: 3.494

6.  Meniscal remodeling following partial meniscectomy--an experimental study in the dog.

Authors:  S P Arnoczky; R F Warren; N Kaplan
Journal:  Arthroscopy       Date:  1985       Impact factor: 4.772

7.  Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.

Authors:  M C Robson; L G Phillips; A Thomason; L E Robson; G F Pierce
Journal:  Lancet       Date:  1992-01-04       Impact factor: 79.321

8.  Cell culture of rabbit meniscal fibrochondrocytes: proliferative and synthetic response to growth factors and ascorbate.

Authors:  R J Webber; M G Harris; A J Hough
Journal:  J Orthop Res       Date:  1985       Impact factor: 3.494

9.  Effects of transforming growth factor beta on proteoglycan synthesis by cell and explant cultures derived from the knee joint meniscus.

Authors:  S Collier; P Ghosh
Journal:  Osteoarthritis Cartilage       Date:  1995-06       Impact factor: 6.576

10.  Meniscal repair using fibrin sealant and endothelial cell growth factor. An experimental study in dogs.

Authors:  J Hashimoto; M Kurosaka; S Yoshiya; K Hirohata
Journal:  Am J Sports Med       Date:  1992 Sep-Oct       Impact factor: 6.202

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.